Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

S'inscrire

BLPH

Bellerophon Therapeutics (PK) (BLPH)

Bellerophon Therapeutics Inc (PK)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:USOTC:BLPH

Date	Heure	Source	Titre	Symbole	Société
04/03/2024	23h25	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
01/03/2024	16h04	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
12/02/2024	21h44	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
14/11/2023	22h31	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
06/11/2023	22h30	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
07/02/2020	18h07	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
27/01/2020	22h51	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
07/01/2020	14h22	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)
27/12/2019	14h26	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:BLPH	Bellerophon Therapeutics Inc (PK)